Medicare Enrolled
Dr. Raju Sarwal, MD
Ophthalmology · Brentwood, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sarwal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sarwal?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sarwal
Dr. Raju Sarwal is an ophthalmology specialist in Brentwood, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sarwal performed 7,117 Medicare services across 5,775 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sarwal received a total of $185,675 from 36 pharmaceutical and/or device companies across 1105 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sarwal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 10% volume in NY
$185,675 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,117
Medicare services
Top 10% in NY for ophthalmology
5,775
Unique beneficiaries
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~375 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
1,117 | $102 | $341 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
1,068 | $32 | $151 |
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
780 | $77 | $177 |
| Optic nerve imaging (OCT scan) Imaging of the optic nerve. |
673 | $31 | $125 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
617 | $54 | $168 |
| Eye drainage system examination An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye. |
609 | $24 | $62 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
408 | $75 | $204 |
| Injection, bimatoprost, intracameral implant, 1 microgram | 380 | $161 | $300 |
| Corneal topography and eye depth measurement This procedure measures the curvature and depth of the cornea, the clear front surface of the eye. |
313 | $24 | $435 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
217 | $100 | $238 |
| Cataract surgery with lens implant Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision. |
160 | $483 | $1,813 |
| Insertion of drug delivery implant into tear duct A small implant containing medication is placed into the tear duct of the eye to deliver drugs directly to the eye over time. |
98 | $15 | $122 |
| Laser removal of recurring cataract A laser procedure to remove a recurring cataract within the lens capsule. |
94 | $290 | $1,874 |
| Laser repair to improve eye fluid flow A laser procedure used to enhance the drainage of fluid within the eye. |
77 | $189 | $2,329 |
| Incision to improve eye fluid flow A surgical procedure involving an incision to enhance the drainage of fluid within the eye. |
61 | $759 | $2,561 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
58 | $117 | $250 |
| Microfluid analysis of tears A laboratory test that analyzes tear fluid using microfluidic technology to measure specific biomarkers. This procedure helps evaluate the composition of tears for diagnostic purposes. |
54 | $22 | $46 |
| New patient eye exam, problem focused A focused examination of the visual system performed during a new patient visit. |
52 | $77 | $180 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
47 | $129 | $313 |
| Cataract removal with artificial lens and drainage device insertion Surgical removal of the eye's natural lens followed by the insertion of an artificial lens and a drainage device into the front chamber of the eye. |
44 | $321 | $2,500 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
40 | $28 | $50 |
| Medication injection into the eye A procedure involving the injection of medication directly into the eye. The specific type of medication or clinical purpose is not defined in the provided description. |
38 | $172 | $592 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
34 | $34 | $126 |
| Laser eye fluid drainage tract creation A laser procedure used to create drainage tracts in the iris to help fluid flow out of the eye. |
33 | $212 | $2,350 |
| Ultrasound scan of cornea to determine thickness An ultrasound procedure used to measure the thickness of the cornea. |
29 | $10 | $102 |
| Laser destruction of lens tissue A procedure that uses a laser to destroy or remove tissue within the eye's lens. |
16 | $368 | $1,600 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.2% high complexity
16.2% medium
81.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$185,675
Total received (2018-2024)
Avg $26,525/year across 7 years
Top 2% in NY for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
1,105
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$168,937 (91.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,276 (6.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,462 (2.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$41,282
2023
$22,938
2022
$29,472
2021
$26,009
2020
$19,578
2019
$25,376
2018
$21,020
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$27,153
NEW WORLD MEDICAL,INC.
$7,169
Alcon Vision LLC
$5,654
Bausch & Lomb Americas Inc.
$422
Oyster Point Pharma, Inc.
$308
SUN PHARMACEUTICAL INDUSTRIES INC.
$259
Glaukos Corporation
$141
BIOTISSUE HOLDINGS INC.
$69
Harrow Eye, LLC
$36
Ocular Therapeutix, Inc.
$33
Rayner Intraocular Lenses Limited
$23
ANI Pharmaceuticals, Inc.
$14
Top 3 companies account for 96.8% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$48,754
Allergan, Inc.
$40,713
Aerie Pharmaceuticals, Inc.
$23,036
AbbVie Inc.
$19,623
Allergan Inc.
$16,147
Alcon Vision LLC
$8,608
NEW WORLD MEDICAL,INC.
$8,465
Bausch & Lomb, a division of Bausch Health US, LLC
$7,893
Glaukos Corporation
$3,924
Alcon Laboratories Inc
$2,261
Oyster Point Pharma, Inc.
$1,279
Novartis Pharmaceuticals Corporation
$974
Bausch & Lomb Americas Inc.
$830
Shire North American Group Inc
$762
Sight Sciences, Inc.
$513
Sun Pharmaceutical Industries Inc.
$346
SUN PHARMACEUTICAL INDUSTRIES INC.
$259
Ocular Therapeutix, Inc.
$211
BioTissue Holdings, Inc.
$179
Ivantis, Inc
$153
RxSight Inc
$152
Kala Pharmaceuticals, Inc.
$104
BIOTISSUE HOLDINGS, INC.
$87
Johnson & Johnson Surgical Vision, Inc.
$80
BIOTISSUE HOLDINGS INC.
$69
Supernus Pharmaceuticals, Inc.
$40
Harrow Eye, LLC
$36
Horizon Therapeutics plc
$35
Mallinckrodt Hospital Products Inc.
$25
Rayner Intraocular Lenses Limited
$23
Thea Pharma Inc.
$19
Dompe US, Inc.
$19
Eyevance Pharmaceuticals LLC
$17
Omeros Corporation
$15
ANI Pharmaceuticals, Inc.
$14
Iridex Corporation
$12
Top 3 companies account for 60.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ALPHAGAN P · AcrySof IQ PanOptix · AcrySof IQ PanOptix UV IOL · AcrySof IQ VIVITY IOL · Ahmed Glaucoma Valve · BEOVU · BESIVANCE · BROMSITE · BromSite (bromfenac ophthalmic solution) 0.075% · CEQUA · COMBIGAN · Catalys Laser System · Centurion · Cequa · Clareon · CyPass · DEXTENZA · DUREZOL · DURYSTA · Discovisc · EYSUVIS · HYDRUS Microstent · HYLENEX RECOMBINANT · Hydrus · Hydrus Microstent · ILEVRO · INVELTYS · ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM · IYUZEH · Kahook Dual Blade · LATANOPROSTENE BUNOD · LOTEMAX · LOTEMAX SM · LUMIGAN · Luxor · MIEBO · NGENUITY · OMNI SURGICAL SYSTEM · OMNI(R) SURGICAL SYSTEM (US) · ORA · ORA System VerifEye · OXERVATE · OZURDEX · Omidria · PROKERA · PROLENSA · PURIFIED CORTROPHIN GEL · PanOptix · RESTASIS · RESTASIS MULTIDOSE · RXSIGHT CONTACT LENS · Radius · ReSTOR · ReSure Sealant · Rhopressa · Rocklatan · SIMBRINZA · STELLARIS · Simbrinza · TEPEZZA · TRAVATAN Z · TYRVAYA · TearCare SmartLid · Tobradex ST · VERITAS Vision System · VEVYE · VUITY · VYZULTA · XIIDRA · XIPERE · ZYLET · enVista MX60 IOL · iSTENT iNJECT TRABECULAR MICRO-BYPASS STENT SYSTEM · iStent Trabecular Micro-Bypass Stent System · iStent inject W · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (91%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for ophthalmology in NY.
Geographic Context
Ophthalmologists within 10 mi
251
Per 100K population
16.5
County median income
$128,329
Nearest hospital
PILGRIM PSYCHIATRIC CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sarwal is a mixed practice specialist, with above-average Medicare volume (top 10% in NY), with speaking/promotional industry engagement in the top 2% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sarwal experienced with comprehensive eye exam, established patient?
Based on Medicare claims data, Dr. Sarwal performed 1,117 comprehensive eye exam, established patient services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sarwal receive payments from pharmaceutical companies?
Yes. Dr. Sarwal received a total of $185,675 from 36 companies across 1,105 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sarwal's costs compare to other ophthalmologists in Brentwood?
Dr. Sarwal's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sarwal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in Brentwood
Browse ophthalmologists in Brentwood ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in NY
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in NY
Which NY ophthalmologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
By company
Aerie Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Aerie Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology